Skip to content
Tenfell
Awarded contract
Published 24 Jul 2024

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

NHS England · London

Key facts

Awarded
30 May 2024
Contract starts
30 Jun 2024
Contract ends
30 Apr 2027
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 9 suppliers

SupplierValue
Takeda UK Limited—
Pfizer Ltd—
Novo Nordisk—
Roche Products Ltd—
Sobi (Swedish Orphan Biovitrum Ltd)—
Octapharma Limited—
Bio Products Laboratory—
CSL Behring UK Ltd—
LFB—

Description

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024

Offer reference number: CM/PHS/22/5661

Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 14 months.

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.